Better Therapeutics News - BTTX

Company Name	Stock Ticker Symbol	Market	Type
Better Therapeutics Inc	BTTX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	0.0446	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
			0.0446	0.0446

more quote information »

Recent News

Date	Time	Source	Heading
3/14/2024	09:38	BW	Better Therapeutics Announces it will Seek Strategic..
3/11/2024	09:01	EDGAR2	Form 8-K - Current report
3/05/2024	09:25	BW	Better Therapeutics Announces an Innovative Partnership with..
3/04/2024	09:25	BW	Better Therapeutics Announces Acceptance of Late Breaking..
3/04/2024	08:51	EDGAR2	Form 8-K - Current report
3/01/2024	06:08	EDGAR2	Form RW - Registration Withdrawal Request
2/20/2024	09:25	BW	Better Therapeutics Receives FDA Breakthrough Device..
2/12/2024	16:28	EDGAR2	Form SC 13D/A - General statement of acquisition of..
2/06/2024	09:43	BW	Better Therapeutics Signs Rebate Agreement with One of the..
2/06/2024	09:02	EDGAR2	Form S-1/A - General form for registration of securities..
1/25/2024	16:30	EDGAR2	Form SC 13D/A - General statement of acquisition of..
1/23/2024	17:22	EDGAR2	Form D - Notice of Exempt Offering of Securities
1/17/2024	09:28	BW	Better Therapeutics Announces Publication of..
1/10/2024	07:01	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
1/08/2024	16:42	EDGAR2	Form 8-K - Current report
1/04/2024	14:00	BW	Better Therapeutics and Glooko Announce Partnership to..
1/02/2024	07:45	BW	Better Therapeutics Announces Submission for FDA..
12/28/2023	21:23	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
12/21/2023	17:21	EDGAR2	Form S-1/A - General form for registration of securities..
12/20/2023	17:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/20/2023	17:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/20/2023	17:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/13/2023	17:24	EDGAR2	Form S-1 - General form for registration of securities under..
12/13/2023	17:06	EDGAR2	Form 8-K - Current report
12/07/2023	20:09	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/30/2023	16:10	EDGAR2	Form 8-K - Current report
11/28/2023	07:45	BW	Better Therapeutics Strengthens Financial Position Through..
11/20/2023	17:08	EDGAR2	Form 8-K - Current report
11/14/2023	07:00	BW	Frost & Sullivan Honors Better Therapeutics with the 2023..
11/09/2023	07:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	07:03	EDGAR2	Form 8-K - Current report
11/09/2023	07:00	BW	Better Therapeutics Reports Third Quarter 2023 Financial..
11/08/2023	07:30	BW	Better Therapeutics to Release Third Quarter 2023 Financial..
10/30/2023	16:14	EDGAR2	Form 8-K - Current report
10/27/2023	16:26	EDGAR2	Form S-1/A - General form for registration of securities..
10/26/2023	07:55	BW	Better Therapeutics to Participate in the American College..
10/16/2023	07:55	BW	Better Therapeutics Announces Launch of AspyreRxTM to Treat..
10/16/2023	07:22	EDGAR2	Form DEF 14A - Other definitive proxy statements
10/12/2023	16:17	EDGAR2	Form S-3/A - Registration statement under Securities Act of..
10/11/2023	07:55	BW	Better Therapeutics Announces New Data Highlighting..
10/06/2023	16:15	EDGAR2	Form PRE 14A - Other preliminary proxy statements
10/05/2023	07:45	BW	Better Therapeutics Announces Publication of LivVita Liver..
9/28/2023	16:16	BW	Better Therapeutics Completes Enrollment in Real-World..
8/25/2023	16:26	EDGAR2	Form S-3/A - Registration statement under Securities Act of..
8/14/2023	16:02	EDGAR2	Form SC 13D/A - General statement of acquisition of..
8/09/2023	16:37	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
8/09/2023	16:09	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/2023	16:07	EDGAR2	Form 8-K - Current report
8/09/2023	16:03	BW	Better Therapeutics Reports Second Quarter 2023 Financial..
8/02/2023	17:30	BW	Better Therapeutics to Release Second Quarter 2023 Financial..